HippoFi Enters Strategic Alliance with Zimmer Biomet

HippoFi entered into a partnership with Zimmer Biomet to introduce a novel synthetic biomaterial for bone growth, set for a 2024 launch under HippoFi’s biologic subsidiary, PUR Biologics.

HippoFi/PUR gained FDA 510(K) clearance for ActiveOrb technology, and secured from Zimmer Biomet an exclusive global license to the underlying technology for...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

  • This field is for validation purposes and should be left unchanged.

0